Status:
RECRUITING
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Malignant Digestive System Neoplasm
Malignant Female Reproductive System Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the use of extended venous thromboembolism prophylaxis (ePPx) following abdominopelvic cancer surgery within the NCI Community Oncology Research Program (NCORP) network, targeting...
Detailed Description
PRIMARY OBJECTIVE: I. To evaluate self-reported utilization of guideline concordant extended venous thromboembolism (VTE) prophylaxis (ePPx) following abdominopelvic cancer surgery within a sample of...
Eligibility Criteria
Inclusion
- SURGEON ELIGIBILITY CRITERIA FOR OPEN STEP 0 ENROLLMENT:
- \* Any surgeon performing gastrointestinal, genitourinary, or gynecologic cancer surgery within an NCORP site, including general surgeons, surgical specialists, urologists, and gynecologists. Surgeons do not need to be involved in research or have a Cancer Therapy Evaluation Program Identification (CTEP ID) to participate in this study
- SURGICAL APP ELIGIBILITY CRITERIA FOR OPEN STEP 0 ENROLLMENT:
- \* APPs providing postoperative care to patients operated by surgeons performing gastrointestinal, genitourinary, or gynecologic cancer surgery within an NCORP site, including general surgeons, surgical specialists, urologists, and gynecologists. Surgical APPs do not need to be involved in research or have a CTEP ID to participate in this study
- SURGEON ELIGIBILITY CRITERIA FOR OPEN STEP 1 ENROLLMENT:
- \* Must have completed the STOP-VTE Survey - Surgeon electronically (preferred) or on paper and have it transferred to Research Electronic Data Capture (REDCap) by the contact person(s)
- SURGICAL APP ELIGIBILITY CRITERIA FOR OPEN STEP 1 ENROLLMENT:
- \* Must have completed the STOP-VTE Survey - APP electronically (preferred) or on paper and have it transferred to REDCap by the contact person(s)
- SITE ELIGIBILITY PART 1-SITE ENROLLMENT IN OPEN:
- \* Have at least one eligible surgeon or surgical APP who completed the STOP-VTE Survey - Surgeon/APP
Exclusion
- N/A
Key Trial Info
Start Date :
December 2 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07215624
Start Date
December 2 2025
End Date
June 1 2027
Last Update
January 6 2026
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mercy Medical Center - Des Moines
Des Moines, Iowa, United States, 50314
2
Wake Forest NCORP Research Base
Winston-Salem, North Carolina, United States, 27157
3
Prisma Health Greenville Memorial Hospital
Greenville, South Carolina, United States, 29605